海外の治験の状況「1」での検索結果
860件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab
- Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 19.0 Level: PT Classification code 10059176 Term: Juvenile idiopathic arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Argentina, Austria, Belgium, Brazil, Canada, France, Germany, Hong Kong, Hungary, Israel, Italy, Mexico, Netherlands, Peru, Poland, Russian Federation, Spain, Sweden, Turkey, United States
- 2014-07-25
Not recruiting
- Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)
- Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus
- Argentina, Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2015-04-09
Not recruiting
- Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)
- Human Immunodeficiency Virus (HIV);Human Immunodeficiency Virus (HIV);Human Immunodeficiency Virus (HIV)
- Australia, Belgium, Canada, Chile, Colombia, Denmark, Germany, Guatemala, Honduras, Israel, Mexico, Netherlands, New Zealand, Peru, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom, United States
- 2015-03-26
Not Recruiting
- Study of AVE5026 at weight-adjusted doses in children with a Central Venous Line
- Prevention of thromboembolism MedDRA version: 14.1 Level: LLT Classification code 10043566 Term: Thromboembolism System Organ Class: 10047065 - Vascular disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Brazil, Canada, Guatemala, Hong Kong, Hungary, Israel, Mexico, Peru, Romania, Russian Federation, Singapore, Slovakia, Spain, Switzerland, Turkey
- 2012-02-06
Not recruiting
- Bone and Body Comp: A Sub Study of the SECOND-LINE Study
- HIV;HIV;HIV;HIV
- Argentina, India, Malaysia, South Africa, Thailand
- 2012-01-16
Not Recruiting
- Pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen as first line treatment for R/M HNSCC (KEYNOTE-669/ECHO-304)
- Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-10-10
Not recruiting
- Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
- HIV Infections;HIV Infections
- Argentina, Australia, Canada, France, Germany, Italy, Korea, Republic of, Mexico, Russian Federation, South Africa, Spain, Sweden, United States
- 2017-09-26
Not recruiting
- Avelumab in First-line Non-Small Cell Lung Cancer (JAVELIN Lung 100)
- First Line Non-Small Cell Lung Cancer
- Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2015-10-13
Not recruiting
- Phase II, 2nd Line Melanoma - RAND Monotherapy
- Melanoma
- Austria, Brazil, Canada, Denmark, France, Germany, Italy, United States
- 2008-01-30
Not recruiting
- Study of Options for Second-Line Effective Combination Therapy (SELECT)
- HIV-1 Infection;HIV-1 Infection;HIV-1 Infection;HIV-1 Infection
- Brazil, India, Kenya, Malawi, Peru, South Africa, Tanzania, Thailand, Zimbabwe
- 2011-01-12
